Clinical Trials Logo

Clinical Trial Summary

Patients needing intensive care often require sedative drugs to reduce anxiety and agitation during ventilator care and invasive therapeutic and diagnostic procedures. At present there is no optimal sedative agent for these patients. The most commonly used sedative agents in intensive care units are midazolam and propofol. Both drugs have side effects of clinical importance. At present, a viable alternative to intravenous sedation is inhalatory sedation. Sevoflurane, as other inhaled anesthetic agents, is sedative in low doses. A new simplified method of administration of isoflurane or sevoflurane has been developed. The Anesthetic Conserving Device is a modified heat-moisture exchanger (HME) that permits direct infusion of sevoflurane to the airway, where it is vaporized in an evaporator rod in the device. However, the use of sevoflurane is limited to anesthesia and sedation lasting no more than 12 hours, since the possible renal problems posed by inorganic fluoride in prolonged operations remain the subject of controversy. The primary aim (and primary hypothesis) of the current trial is to determine whether sevoflurane can be administered as a sedative drug for more than 48 hours without clinically relevant physiopathological effects on kidney and liver function. Other end-points of the trial are to evaluate the quality of sedation of sevoflurane, in terms of sedation control, the rapidity and predictability of awakening, and the incidence of delirium in critical care patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01802255
Study type Interventional
Source Fundación para la Investigación del Hospital Clínico de Valencia
Contact
Status Withdrawn
Phase Phase 3
Start date March 2013
Completion date June 2015

See also
  Status Clinical Trial Phase
Completed NCT01217736 - Direct Renin Inhibition and the Kidney Phase 1
Completed NCT04742816 - Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients Phase 4
Completed NCT01598987 - Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. Phase 3
Completed NCT00992043 - Creatine Supplementation and Diabetes N/A
Recruiting NCT04334135 - The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function N/A
Completed NCT04940260 - Soluble Factors and Renal Outcome in Preeclampsia
Recruiting NCT02288663 - Renal Function Assessment in the Elderly Using Plasma Creatinine Assay and Lean Body Mass Measurement N/A
Completed NCT01227213 - The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma N/A
Completed NCT03228563 - The Effect of Probiotics on Chronic Kidney Disease N/A
Completed NCT01680744 - The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup N/A
Completed NCT05179564 - Renal Function Assessment in Critically Ill Children N/A
Recruiting NCT05503147 - Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan) Phase 1
Not yet recruiting NCT05813730 - Urinary Creatinine Excretion Time in the Neonatal Period N/A
Completed NCT01320722 - Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function N/A
Completed NCT01925235 - Analysis of Remote-ischemic Preconditioning Effects on Kidney Function N/A
Completed NCT01138241 - Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Completed NCT00634920 - Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients Phase 4
Recruiting NCT03170739 - Effects of Dexmedetomidine and Dopamine on Renal Function After Major Surgery Phase 4
Completed NCT00117390 - Evaluation of the Optimal Technique for Determination of Renal Function of Critically Ill Patients N/A
Completed NCT03605810 - Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data